LIVEBETTER (a trial comparing the effectiveness and tolerability of medications in older adults with stable angina and multiple chronic conditions)
- Study HIC#:2000034470
- Last Updated:05/03/2024
The purpose of the LIVEBETTER study is to learn how older patients with heart disease tolerate the two primary medication groups that are currently available to treat symptoms of angina. The study will compare how Beta-Blocker and Calcium Channel Blocker medications work to improve patients’ symptoms and overall quality of life. People who participate will be randomly assigned to one of these two groups of medications, and they will be followed for one year with interviews and a short walk assessment.
Contact information:
Michael G. Nanna, MD, MHS, FSCAI, FACC
Section of Cardiovascular Medicine
Yale School of Medicine
Email: livebetter-trial@yale.edu
Toll-Free: (888) 683-0865 – please state you are calling about the LIVEBETTER heart study.
Contact Us
For more information about this study, including how to volunteer, contact:
Michael G. Nanna, MD, MHS, FSCAI, FACC
- Phone Number: 1-888-683-0865
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
The purpose of the LIVEBETTER study is to learn how older patients with heart disease tolerate the two primary medication groups that are currently available to treat symptoms of angina. The study will compare how Beta-Blocker and Calcium Channel Blocker medications work to improve patients’ symptoms and overall quality of life. People who participate will be randomly assigned to one of these two groups of medications, and they will be followed for one year with interviews and a short walk assessment.
Eligibility Criteria
Age: 70 years and older (65 years and older for Black/African American and Hispanic participants)
Gender: Both
Health History: Heart disease with symptoms; NOT currently taking a Beta-Blocker or Calcium Channel Blocker medication
Principal Investigator
- Score: 1
